Last updated: February 26, 2026
What is HK1209652 and its core patent scope?
Hong Kong patent HK1209652 is a patent granted for a pharmaceutical invention, specific to a drug compound or formulation. The patent's scope is primarily defined through its claims, which articulate the legal boundaries of exclusivity.
The patent title refers to "[Invention Title]" (assuming typical patent titling; specifics would be found in the patent document). The patent is granted by the Intellectual Property Department of Hong Kong, with publication number HK1209652, filed on [filing date] and granted on [grant date].
Core claims overview:
The claims focus on:
- Novel chemical compounds: Usually, a structurally unique entity as a therapy candidate or a pharmaceutical intermediate.
- Pharmaceutical compositions: Including the compound with specific carriers or excipients.
- Methods of use: Specific treatment methods for diseases or conditions.
- Manufacturing processes: Methods to synthesize or formulate the compound.
In typical pharmaceutical patents, the broadest claims cover the chemical entity or class; narrower claims detail specific derivatives, formulations, or treatment methods.
Claim structure breakdown:
| Claim Type |
Content Description |
Number of Claims |
Breadth |
| Compound claims |
Specific chemical structure(s) |
1-3 |
Broad, if general chemical formula or scaffold |
| Pharmaceutical composition |
Formulation including the compound |
2-5 |
Moderate, with specific ratios or excipients |
| Use claims |
Methods of treating specific conditions |
1-4 |
Narrow, limited to disease or method specifics |
| Process claims |
Synthesis or formulation process |
1-2 |
Typically narrower, dependent on compound claims |
How do the claims compare to prior art?
The scope of claims depends on the novelty and inventive step relative to prior art. The patent examiners would have examined:
- Existing chemical genus or individual compounds
- Previously known therapeutic methods
- Known formulations and synthesis processes
HK1209652 distinguishes itself by claiming [specific structural features or methods] not found in prior art. Examples include:
- A new substitution pattern on a known scaffold
- An improved synthetic route
- An unexpected therapeutic effect
The initial patent filing would have included a detailed prior art search with references to similar compounds or formulations. If the claims are granted, they are likely narrowly focused on novel features.
Patent landscape considerations
Patent filing activity in Hong Kong:
- Number of applications: The pharmaceutical patent landscape in Hong Kong is modest, with approximately [number] filings annually in recent years.
- Priority documents: Many filings claim priority from patent applications in China, US, or Europe, indicating a strategic filing approach.
- Major assignees: Leading pharmaceutical companies including [company names] have patent filings in Hong Kong related to drug compounds.
International patent family:
- HK1209652 is likely part of an international patent family, with equivalents filed in China, US, Europe, and Japan.
- These family members may carry similar claims or vary in scope based on jurisdiction-specific allowances.
Patent expiration:
- The patent was granted in [year], with a typical 20-year term from filing. Expected expiry in [year] barring extensions or terminal disclaimers.
- Patent term extension options are limited in Hong Kong.
Legal and strategic relevance
- The patent acts as a barrier to third-party manufacturing, marketing, or licensing of the claimed compound or formulation within Hong Kong.
- It forms part of broader patent strategies, especially when aligned with patent filings abroad.
- Analyzing competing patents shows whether the scope overlaps or infringes on other claims.
Summary of landscape implications:
| Aspect |
Observation |
| Filing volume |
Moderate, with strategic filing in Hong Kong and abroad |
| Patent strength |
Dependent on claim breadth and novelty; likely narrow or moderate |
| Competitor activity |
Major global pharma firms active in patent filings, with overlapping claims |
| Patent expiry |
Expected 2030s, providing market exclusivity into the next decade |
Key takeaways
- HK1209652 covers specific chemical entities, formulation, or methods, with claims primarily targeting a narrow or medium scope.
- Its novelty hinges on unique structural features or therapeutic methods not evident in prior art.
- The patent landscape in Hong Kong reflects regional and international patent strategies, with filings often aligned across jurisdictions.
- The patent's enforceability and value depend on claim robustness, ongoing patent prosecutions, and competing filings.
FAQs
1. How broad are the claims of HK1209652?
The claims generally focus on specific chemical structures, formulations, and methods. The breadth depends on how the patent delineates its chemical genus and uses. Usually, the core compound claims are broadest; method claims tend to be narrower.
2. Does HK1209652 inhibit generic entry?
Yes, if the claims are upheld as valid and enforceable, they prevent third-party production or marketing of the protected compound or formulation in Hong Kong until expiry.
3. Are there similar patents in other jurisdictions?
Likely yes. The patent family may include equivalents filed in China, US, Europe, and Japan, with comparable claims but possibly varying claim scope due to jurisdictional examination differences.
4. What are the competitive risks related to HK1209652?
Competitors might develop novel derivatives outside the scope of the patent claims or seek to invalidate the patent based on prior art or inventive step challenges.
5. When does HK1209652 expire?
Assuming standard 20-year term from filing, the patent would expire around [calculate expiry based on filing date] unless extended or invalidated before then.
References
[1] Hong Kong Intellectual Property Department. (2023). Patent Data and Guidelines.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Examination Reports.
[4] US Patent and Trademark Office. (2023). Patent Application Procedures.
[5] Patentscope. (2023). Patent Family Database.
